J.W. Cole Advisors’s ARS Pharmaceuticals SPRY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-20,520	Closed	-$298K	–	994
2024 Q3	$298K	Buy	20,520 +5,120	+33%	+$74.2K	0.01%	774
2024 Q2	$131K	Buy	15,400 +1,500	+11%	+$12.8K	0.01%	867
2024 Q1	$142K	Buy	+13,900	New	+$142K	0.01%	848